Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,655   13.81  Index Moved Down -0.83%
ABT MDT SYK ISRG Insurance Hotels Large Blend Government 
United States GSPC USD ...  |  Investing Themes


Processing
Processing. Please wait...

Boston insider: Kenneth Pucel

       

Kenneth Pucel - Boston Insider Profile

Executive VP of Global Operations, Quality and Technology

Mr. Kenneth J. Pucel is an Executive Vice President Global Operations, Quality and Technology of Boston Scientific Corporationrationration since December 2012. Mr. Pucel was previously Executive Vice President, Global Operations and Technology from January 2011 to December 2012, at which time he assumed responsibility for the Company Global Quality function. Prior to this, he served as Executive Vice President, Operations from November 2006 to 2011, Senior Vice President, Operations from December 2004 to November 2006, Vice President and General Manager, Operations from September 2002 to December 2004 and Vice President of Operations from June 2001 to September 2002. Prior to that, he held various positions in Cardiovascular Group, including Manufacturing Engineer, Process Development Engineer, Operations Manager, Production Manager and Director of Operations
Age: 45  EVP Since 2012      
Kenneth Pucel EducationPucel earned a B.S. degree in Mechanical Engineering with a focus on Biomedical Engineering from the University of Minnesota.

Management Efficency

The company has Return on Asset of 3.1 % which means that on every $100 spent on asset it made $3.1 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of (50.67) % meaning that it generated no profit with money invested by stockholders.
The company has 4.25 B in debt with debt to equity (D/E) ratio of 0.65 which is OK given its current industry classification. Boston Scientific Corporation has Current Ratio of 1.86 which is typical for the industry and considered as normal.
    

Other Executives

Michael Mahoney, CEO, MBA
Peter Nicholas, Chairman, MBA
Wendy Carruthers, President
Supratim Bose, President, MBA
Karen Prange, President
Keith Dawkins, President
Kevin Ballinger, President, MBA
Maulik Nanavaty, President, MBA
Jeffrey Mirviss, President, MBA
Otha Spriggs, President
David Pierce, President, MBA
Michael Phalen, President, MBA
Joseph Fitzgerald, President, MBA
Jean Lance, President
Michael Campbell, President
John Onuscheck, President
Lawrence Neumann, President
Jeffrey Capello, CFO
Brian Burns, EVP
Timothy Pratt, EVP
Bruce Byrnes, Director
Uwe Reinhardt, Director, Ph.D
Ernest Mario, Director
N Nicholas, Director, MBA
John Sununu, Director, MBA
Nelda Connors, Director
Kristina Johnson, Director
Katharine Bartlett, Director
William Kucheman, Executive, MBA

Entity Summary

Boston Scientific Corporationration develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific Corporation [BSX] is traded on New York Stock Exchange in USA. It is located in Natick, MA and employs 24,000 people. Filter other
    
Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 
    
    
BSX United States NYSE
Boston Scientific Corporation
Benchmark S&P 500
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
    
Chance of
Bankruptcy
Less
Than
43%
In The Next
Two Years
Boston Scientific Corporation has less than 43.4 (%) percent chance of experiencing financial distress in the next 2 years of operations.
    
    

Boston price boundaries

    
April 22 2013
 7.26 
  
 7.27 
0.0100  Macroaxis: 0.137741046831953 Up   0.14%  
Lowest period price (30 days)
May 20 2013
 9.15 
  
 9.25 
0.10  Macroaxis: 1.092896174863384 Up   1.09%  
Highest period price (30 days)
    

Promote Boston and Kenneth Pucel

Follow Boston with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Boston to your reader
 

Today Change

 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States SP 500   0.83 % Macroaxis: 0.83 Moved Down  
 
 United States NYSE   0.94 % Macroaxis: 0.94 Moved Down  
 
 thisRed BSX BSX agains markets  1.08 % Macroaxis: change 1.08 Moved Down  
 
 United States Russel   1.65 % Macroaxis: change 1.65 Moved Down  
 

Stock Performance

Shares Outstanding1.35 B
Number of Shares Shorted34.41 M


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium